IBDEI19O ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21183,1,4,0)
 ;;=4^I69.892
 ;;^UTILITY(U,$J,358.3,21183,2)
 ;;=^5007548
 ;;^UTILITY(U,$J,358.3,21184,0)
 ;;=I69.351^^101^1027^39
 ;;^UTILITY(U,$J,358.3,21184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21184,1,3,0)
 ;;=3^Hemiplga fol cerebral infrc aff right dominant side
 ;;^UTILITY(U,$J,358.3,21184,1,4,0)
 ;;=4^I69.351
 ;;^UTILITY(U,$J,358.3,21184,2)
 ;;=^5007504
 ;;^UTILITY(U,$J,358.3,21185,0)
 ;;=I69.352^^101^1027^38
 ;;^UTILITY(U,$J,358.3,21185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21185,1,3,0)
 ;;=3^Hemiplga fol cerebral infrc aff left dominant side
 ;;^UTILITY(U,$J,358.3,21185,1,4,0)
 ;;=4^I69.352
 ;;^UTILITY(U,$J,358.3,21185,2)
 ;;=^5007505
 ;;^UTILITY(U,$J,358.3,21186,0)
 ;;=I69.353^^101^1027^40
 ;;^UTILITY(U,$J,358.3,21186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21186,1,3,0)
 ;;=3^Hemiplga fol cerebral infrc aff right nondom side
 ;;^UTILITY(U,$J,358.3,21186,1,4,0)
 ;;=4^I69.353
 ;;^UTILITY(U,$J,358.3,21186,2)
 ;;=^5007506
 ;;^UTILITY(U,$J,358.3,21187,0)
 ;;=I69.354^^101^1027^41
 ;;^UTILITY(U,$J,358.3,21187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21187,1,3,0)
 ;;=3^Hemiplga fol cerebral infrc affecting left nondom side
 ;;^UTILITY(U,$J,358.3,21187,1,4,0)
 ;;=4^I69.354
 ;;^UTILITY(U,$J,358.3,21187,2)
 ;;=^5007507
 ;;^UTILITY(U,$J,358.3,21188,0)
 ;;=I69.151^^101^1027^44
 ;;^UTILITY(U,$J,358.3,21188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21188,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,21188,1,4,0)
 ;;=4^I69.151
 ;;^UTILITY(U,$J,358.3,21188,2)
 ;;=^5007441
 ;;^UTILITY(U,$J,358.3,21189,0)
 ;;=I69.152^^101^1027^42
 ;;^UTILITY(U,$J,358.3,21189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21189,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,21189,1,4,0)
 ;;=4^I69.152
 ;;^UTILITY(U,$J,358.3,21189,2)
 ;;=^5007442
 ;;^UTILITY(U,$J,358.3,21190,0)
 ;;=I69.153^^101^1027^45
 ;;^UTILITY(U,$J,358.3,21190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21190,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,21190,1,4,0)
 ;;=4^I69.153
 ;;^UTILITY(U,$J,358.3,21190,2)
 ;;=^5007443
 ;;^UTILITY(U,$J,358.3,21191,0)
 ;;=I69.154^^101^1027^43
 ;;^UTILITY(U,$J,358.3,21191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21191,1,3,0)
 ;;=3^Hemiplga fol ntrm intcrbl hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,21191,1,4,0)
 ;;=4^I69.154
 ;;^UTILITY(U,$J,358.3,21191,2)
 ;;=^5007444
 ;;^UTILITY(U,$J,358.3,21192,0)
 ;;=I69.851^^101^1027^50
 ;;^UTILITY(U,$J,358.3,21192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21192,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right dominant side
 ;;^UTILITY(U,$J,358.3,21192,1,4,0)
 ;;=4^I69.851
 ;;^UTILITY(U,$J,358.3,21192,2)
 ;;=^5007535
 ;;^UTILITY(U,$J,358.3,21193,0)
 ;;=I69.852^^101^1027^51
 ;;^UTILITY(U,$J,358.3,21193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21193,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left dominant side
 ;;^UTILITY(U,$J,358.3,21193,1,4,0)
 ;;=4^I69.852
 ;;^UTILITY(U,$J,358.3,21193,2)
 ;;=^5007536
 ;;^UTILITY(U,$J,358.3,21194,0)
 ;;=I69.853^^101^1027^52
 ;;^UTILITY(U,$J,358.3,21194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21194,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff right nondom side
 ;;^UTILITY(U,$J,358.3,21194,1,4,0)
 ;;=4^I69.853
 ;;^UTILITY(U,$J,358.3,21194,2)
 ;;=^5007537
 ;;^UTILITY(U,$J,358.3,21195,0)
 ;;=I69.854^^101^1027^53
 ;;^UTILITY(U,$J,358.3,21195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21195,1,3,0)
 ;;=3^Hemiplga fol oth cerebvasc disease aff left nondom side
